UFP Technologies, Inc.
Financials
Valuation Metrics
UFP Technologies, Inc.'s Market Cap is $2.14B. At end of 2025 it was $1.71B. Ranked #1979 of 3,121 in US market (top 63%), #752 of 1,463 on NASDAQ (top 51%), #117 of 205 in Health Care Equipment & Services (top 57%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.14B | US#1,979/3,121 Sec#117/205 |
| Revenue | $632M | US#2,160/3,121 Sec#133/205 |
| Net Income | $72M | US#1,743/3,121 Sec#88/205 |
| Total Assets | $682M | US#2,644/3,121 Sec#144/205 |
| Net Assets | $462M | US#2,285/3,121 Sec#117/205 |
| Employees | 4,846 | US#1,251/3,121 Sec#89/205 |
| Value | ||
| P/E | 29.61x | US#1,560/3,121 Sec#60/205 |
| P/B | 4.63x | US#2,144/3,121 Sec#126/205 |
| PEG | 3.82x | US#1,172/3,121 Sec#62/205 |
| P/S | 3.39x | US#1,870/3,121 Sec#131/205 |
| EV/EBITDA | 19.66x | US#1,868/3,121 Sec#84/205 |
| FCF Yield | 2.87% | US#1,860/3,121 Sec#108/205 |
| Profitability | ||
| ROE | 15.63% | US#849/3,121 Sec#36/205 |
| ROA | 10.60% | US#443/3,121 Sec#25/205 |
| Op. Margin | 15.25% | US#1,198/3,121 Sec#43/205 |
| Revenue Growth | 7.32% | US#1,552/3,121 Sec#108/205 |
| Earnings Growth | 7.74% | US#1,137/3,121 Sec#64/205 |
| Financial Health | ||
| Debt Ratio | 47.46% | US#536/3,121 Sec#59/205 |
| Total Debt | $136M | US#2,356/3,121 Sec#132/205 |
| FCF | $61M | US#1,912/3,121 Sec#116/205 |
| Cash | $9M | US#2,985/3,121 Sec#201/205 |
| Current Ratio | 3.00x | US#795/3,121 Sec#79/205 |
| Net Debt/EBITDA | 1.10x | US#1,003/3,121 Sec#57/205 |
| Performance | ||
| 1Y Return | 37.25% | US#816/3,121 Sec#68/205 |
| 1M Return | -11.56% | US#2,645/3,121 Sec#179/205 |
| From 52W High | -18.31% | US#1,410/3,121 Sec#97/205 |
| 1Y MDD | -30.69% | US#1,473/3,121 Sec#68/205 |
| Trading | ||
| Volume | 133,062 shares | US#2,960/3,121 Sec#199/205 |
| Trading Value | $37M | US#1,773/3,121 Sec#123/205 |
| Per Share | ||
| EPS | $9.34 | US#319/3,121 Sec#21/205 |
| BPS | $59.77 | US#312/3,121 Sec#26/205 |
Company Info
UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing. It also offers equipment protection and packaging for firearms, unmanned aerial vehicles/drones, weapon systems, electronic devices communications equipment, and tools and repair kits; cushion and protective packaging; acoustic and thermal insulation components for automotive, aerospace, consumer, and industrial; filtration for small engines, air conditioners, humidifiers, refrigerators, electronic air cleaners, forced air appliances and industrial compressors; fluid management; and seals and gaskets for automotive manufacturing chemical processing, building and construction applications. In addition, the company provides uniform and tactical gear for backpack straps and padding, uniform knee and elbow pads, duty belts, holsters, and helmet padding and others; sports and leisure for custom helmet linings, athletic braces, and shoe insoles; and trim and structural components, such as load floors, sunshades, package trays, back panel, and seat backs. The company serves the medical, aerospace and defence, automotive, consumer, electronics, and industrial markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.